Passive Equities

First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the Nasdaq US Smart PharmaceuticalsTM Index (the “Index”).

$26.16

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Nasdaq Pharmaceuticals ETF FTXH
Fund Size
$15.2 Million
Dividend
1.8%
Fees
0.60%
Total Stock Market Index Fund VTI
Fund Size
$1.7 Trillion
Dividend
1.3%
Fees
0.03%
Total Stock Market Index Fund VTSAX
Fund Size
$1.7 Trillion
Dividend
-
Fees
-
500 Index Fund VFINX
Fund Size
$1.32 Trillion
Dividend
-
Fees
-
500 Index Fund VFIAX
Fund Size
$1.32 Trillion
Dividend
-
Fees
-
View 1311 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $130 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.43 %
Beta Indicates the relationship between the price performance of a share and the market. 0.572
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 34.59
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -45.85
Profitable Companies 77
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 148.52
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.91
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 8.12
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 36.07
Enterprise Value to Revenue Enterprise value divided by revenue 5.02
Total Debt to Enterprise Value Total debt divided by enterprise value 0.17
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 5.2771
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 12.39%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 3792.32%
Return on Assets Indicates a company's profitability in relation to its total assets. 192.87%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 386.70%

Industries

Healthcare 94.1%
Finance 2.0%
Industrials 2.0%
N/A 2.0%

Market cap

Micro Cap 2%
Small Cap 0%
Mid Cap 24%
Large Cap 56%
Mega Cap 18%

51 Investments

P/E-Ratio
Total Investment
Weight
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
-16.7
Total Investment
$1.16 Million
Weight
7.6%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
17.3
Total Investment
$1.14 Million
Weight
7.5%
AbbVie Inc logo

ABBV - Manufacturing

AbbVie Inc

P/E-Ratio
80.5
Total Investment
$1.13 Million
Weight
7.5%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
11.9
Total Investment
$1.1 Million
Weight
7.3%
Pfizer Inc logo

PFE - Manufacturing

Pfizer Inc

P/E-Ratio
17.7
Total Investment
$1.08 Million
Weight
7.2%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
26.8
Total Investment
$572 Thousand
Weight
3.8%
Zoetis Inc logo

ZTS - Manufacturing

Zoetis Inc

P/E-Ratio
29.2
Total Investment
$557 Thousand
Weight
3.7%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
23.0
Total Investment
$554 Thousand
Weight
3.7%
Biogen Inc logo

BIIB - Manufacturing

Biogen Inc

P/E-Ratio
12.9
Total Investment
$551 Thousand
Weight
3.6%
United Therapeutics Corp logo

UTHR - Manufacturing

United Therapeutics Corp

P/E-Ratio
10.5
Total Investment
$545 Thousand
Weight
3.6%
Viatris Inc logo

VTRS - Finance and Insurance

Viatris Inc

P/E-Ratio
-2.8
Total Investment
$534 Thousand
Weight
3.5%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
12.6
Total Investment
$513 Thousand
Weight
3.4%
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
66.3
Total Investment
$507 Thousand
Weight
3.3%
Jazz Pharmaceuticals PLC logo

JAZZ - Manufacturing

Jazz Pharmaceuticals PLC

P/E-Ratio
13.7
Total Investment
$489 Thousand
Weight
3.2%
Organon & Co logo

OGN - Manufacturing

Organon & Co

P/E-Ratio
3.5
Total Investment
$408 Thousand
Weight
2.7%
Charles River Laboratories Int logo

CRL - Professional, Scientific, and Technical Services

Charles River Laboratories Int

P/E-Ratio
-240.0
Total Investment
$295 Thousand
Weight
2.0%
Exelixis Inc logo

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

P/E-Ratio
18.0
Total Investment
$285 Thousand
Weight
1.9%
Medpace Holdings Inc logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings Inc

P/E-Ratio
21.8
Total Investment
$262 Thousand
Weight
1.7%
Elanco Animal Health Inc logo

ELAN - Manufacturing

Elanco Animal Health Inc

P/E-Ratio
18.3
Total Investment
$243 Thousand
Weight
1.6%
Illumina Inc logo

ILMN - Manufacturing

Illumina Inc

P/E-Ratio
-14.3
Total Investment
$235 Thousand
Weight
1.6%
Halozyme Therapeutics Inc logo

HALO - Manufacturing

Halozyme Therapeutics Inc

P/E-Ratio
13.7
Total Investment
$229 Thousand
Weight
1.5%
Neurocrine Biosciences Inc logo

NBIX - Manufacturing

Neurocrine Biosciences Inc

P/E-Ratio
40.6
Total Investment
$198 Thousand
Weight
1.3%
BioMarin Pharmaceutical Inc logo

BMRN - Manufacturing

BioMarin Pharmaceutical Inc

P/E-Ratio
20.5
Total Investment
$197 Thousand
Weight
1.3%
Alkermes PLC logo

ALKS - Manufacturing

Alkermes PLC

P/E-Ratio
13.8
Total Investment
$167 Thousand
Weight
1.1%
Corcept Therapeutics Inc logo

CORT - Manufacturing

Corcept Therapeutics Inc

P/E-Ratio
54.9
Total Investment
$147 Thousand
Weight
1.0%